Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
acute necrotizing encephalitis
acyclovir
advances in neurology
adverse drug reaction
altered states of consciousness
alternative medicine
amyotrophic lateral sclerosis
anticonvulsants
antiviral agents
asymptomatic
attention span
autoimmune disease
behavior modification
behavioral disorder
bladder dysfunction
blood dyscrasias, neurologic findings with
brain biopsy
brain scan
breast feeding
calcification, intracranial
caloric testing
cancer, cerebrovascular accident complicating patients with
carcinoma
carcinoma of lung
cataracts, congenital
cerebral infarction, hemorrhagic
cerebral palsy
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebrospinal fluid, cytology
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, xanthochromia of
cerebrovascular accident
cerebrovascular accident, rehabilitation of
cerebrovascular accident, thrombolytic agents in treatment
children
chills
chorioretinitis
cladribine
complementary medicine
compliance
complications
concentration, impaired
concussion
controversies in neurology
conversion reaction
cop 1
cost
cost effectiveness
cyst, porencephalic
cytomegalic inclusion disease
cytosine arabinoside
dementia
demyelinating disease
depression
depression, psychotic
dermatomyositis
diabetes mellitus
diagnostic criteria
disability rating scale, neurological
disability, neurological
dizziness
drug induced neurologic disorders
dural arteriovenous malformation
dural sinus thrombosis
efficacy
electroencephalogram
electron microscopy
electronystagmography
electronystagmography, abnormal
emotional lability
encephalitis
encephalitis, brainstem
encephalitis, clinical picture and treatment of
encephalitis, diagnosis of
encephalitis, viral
encephalitis, viral-causes of
epidemiology of neurology
episodic disorders
evidence-based research
extinction on double simultaneous stimulation
eye movement, disorders of
facial nerve palsy
facial weakness
fatigue
fever
fibrinolytic agents
fibrinolytic agents, complications
fibromyalgia
fingolimod
flu-like illness
gadolinium
gag reflex, depressed
gait disorder
gammaglobulin therapy, intravenous
glioblastoma multiforme(astrocytoma Gr.III)
Guillain Barre syndrome
head injury
headache
herpes labialis
herpes simplex encephalitis
herpes simplex encephalitis, differential diagnosis of
herpes simplex encephalitis, recurrent
herpes simplex encephalitis, treatment of
herpes simplex myelitis
herpes simplex virus
herpes simplex virus infection, immunosuppressed patient
herpes simplex virus, human nervous system and
herpes simplex virus, localization of
herpes simplex virus, malignancy with
herpes simplex virus, pathogenesis of
herpes simplex virus, pathology of
herpes simplex, neurocutaneous lesions in
herpes virus
herpes zoster
herpes, genital
hormone replacement
human herpesvirus 6
hydrocephalus
hypochondriasis
hypoglycorrhachia
iatrogenic neurologic disorders
imbalance
imbalance, postural
immunofluorescent exam of CSF cells
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
inclusion bodies, intranuclear
inclusion body myositis
infectious mononucleosis
interferon
interferon antibodies
interferon beta 1-a
interferon beta 1-b
interferon inducer
internet
intracerebral hemorrhage
intracranial pressure, increased
intrauterine infection, viral
intrauterine infection, viral of CNS
iododeoxyuridine
leukopenia
level of consciousness, decreased
limbic encephalitis
limbic system
liver function enzymes
lymphopenia
malformation, CNS, congenital
marihuana
medical-legal aspects of neurology
meningitis
meningitis, aseptic
mental status, abnormal
methotrexate
microcephaly
micropthalmia
mitoxantrone
monoamines
monoamines, brain
monoclonal antibodies
motor dysfunction
motor neuron disease
movement disorder
movement disorder, psychogenic
MRI
MRI, abnormal
MRI, ADC maps
MRI, contrast enhanced
MRI, demyelinating disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, incidental finding
MRI, serial
MRI, volumetry
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, asymptomatic
multiple sclerosis, diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, monosymptomatic
multiple sclerosis, prognosis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, telling patient diagnosis of
multiple sclerosis, treatment of
muscle pain
muscular dystrophy
myasthenia gravis
myasthenia gravis, treatment of
myasthenic syndrome
myasthenic syndrome, treatment of
myelitis
myofascial pain syndrome
myopathy
natalizumab
neglect
neoplasm, primary intracerebral
neurologic complications of, systemic cancer
neurologic consultation
neurologic disease
neurologic disease, diagnoses of
neurologic disease, incurable
neurologic evaluation
neurologist
neuropathy
neuropathy, multifocal
neuropathy, peripheral, treatment
nystagmus
nystagmus, positional
ocular dysmetria
optic atrophy
optokinetic nystagmus(O.K.N.)
optokinetic nystagmus, abnormal
oral contraceptives
oral contraceptives, neurologic complications with
outcome research
oxybutynin
pathologic reflex
patient information and support
Persistent postural-perceptual dizziness
personality change
physician as patient
plasmapheresis
pleocytosis of cerebrospinal fluid
pneumonia
polyinosinic cytidic acid(poly IC)
polyneuropathy, chronic inflammatory demyelinating
practice guidelines
precipitating factors
pregnancy, neurologic complications in
pressure sores
prethrombotic state
primary intracranial hypotension
prognosis
progressive multifocal leucoencephalopathy
psychiatric disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
pursuit eye movements
quality of life
rehabilitation for neurologic disorders
remote effect of cancer on the nervous system
review article
risk factors
rubella virus
saccadic eye movements
seizure
seizure, psychomotor-temporal lobe
seizure, treatment of
selective serotonin reuptake inhibitors
serologic testing
serotonin norepinephrine reuptake inhibitors
serum glutamic oxaloacetic transaminase
sexual dysfunction in neurologic disease
spasticity
spatial neglect
spinal cord
spinal cord, injury of
spinal cord, injury, complications with
spinal cord, injury, functional capacity of patient with
spinal cord, injury, prognosis in
spinal cord, injury, sexual dysfunction in
stem cell tourism
stem cell transplantation
steroid
steroid therapy, CNS treatment and complications with
stiff man syndrome
subacute myelo-opticoneuropathy(S.M.O.N.)complex
subspecialist
subtemporal decompression
systemic illness
talk
teleconsulting
telemedicine
teleneurology
telestroke
tender points
thoracic outlet syndromes
tissue plasminogen activator, intravenous
transplacental virus infections
trauma
treatment of neurologic disorder
trigeminal neuralgia
urinary tract infection
viral infection
viral infection, CNS
walking
weakness
workers' compensation
Showing articles 300 to 350 of 4627 << Previous Next >>

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012

"Undiagnosing" Multiple Sclerosis
Neurol 78:1986-1991,1904, Solomon, A.J.,et al, 2012

Distinct Lesion Morphology at 7-T MRI Differentiates Neuromyelitis Optica from Multiple Sclerosis
Neurol 79:708-714, Sinnecker, T.,et al, 2012

Painful Tonic Spasm in Neuromyelitis Optica
Arch Neurol 69:1026-1031, Kim, S.M.,et al, 2012

Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis
Arch Neurol 69:1259-1269, Radue, E.W.,et al, 2012

Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS
Neurol 77:2010-2016, Kuhle, J.,et al, 2011

Inflammatory Cortical Demyelination in Early Sclerosis
NEJM 365:2188-2197, Lucchinetti, C.F.,et al, 2011

Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis
Neurol 77:2128-2134, Scott, T.F.,et al, 2011

Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)
Arch Neurol 68:455-462, Kedia, S.,et al, 2011

Efficacy and Safety of Mitoxantrone in Patients with Highly Relapsing Neuromyelitis Optica
Arch Neurol 68:473-479, Kim, S.H.,et al, 2011

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
Neurol 76:1858-1865, OConnor, P.W.,et al, 2011

Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy
Neurol 77:62-66, Schade van Westrum, S.M.,et al, 2011

Rhombencephalitis A Series of 97 Patients
Medicine 90:256-261, Moragas, M.,et al, 2011

Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome
The Neurologist 17:179-184, Comi, A.M., 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Paraneoplastic isolated myelopathy Clinical course and neuroimaging clues
Neurol 76:2089-2095, Flanagan, E.P.,et al, 2011

Predicting motor outcome and death in term hypoxic-ischemic encephalopathy
Neurol 76:2055-2061, Martinez-Biarge, M.,et al, 2011

Sustained motion perception deficit following optic neuritis Behavioral and cortical evidence
Neurol 76:2103-2111, Raz, N.,et al, 2011

Disability, distress and unemployment in neurology outpatients with symptoms unexplained by organic disease
JNNP 82:810-813, 710, Carson, A.,et al, 2011

Cost-effectiveness of disease-modifying therapy for multiple sclerosis
Neurol 77:355-363, Noyes, K.,et al, 2011

Improved Late Survival and Disability After Stroke With Therapeutic Anticoagulation for Atrial Fibrillation
Stroke 42:2503-2508, Hannon, N.,et al, 2011

Balos Concentric Sclerosis
NEJM 365:742, Wengert, O.,et al, 2011

Azathioprine
Neurol 77:659-666, Costanzi, C.,et al, 2011

Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011

N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-Myoclonus
Arch Neurol 68:1069-1072, Smith, J.H.,et al, 2011

Drug-Resistant Epilepsy
NEJM 365:919-26, Kwan, P.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Optic Neuritis: Prognosis and Treatment
UpToDate, Jan, Osborne, B.,et al, 2011

Yellow Fever Vaccination and Increased Relapse Rate in Travelers with Multiple Sclerosis
Arch Neurol 68:1267-1271, Farez, M.F. and Correale, J., 2011

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
NEJM 365:1293-1303, OConnor, P.,et al, 2011

Acute Myeloid Leukemia in Italian Patients with Multiple Sclerosis Treated with Mitoxantrone
Neurol 77:1887-1895, Martinelli, V.,et al, 2011

Multiple Sclerosis-Quenching the Flames of Inflammation
Lancet 378:1759-1760, , 2011

A Strange Case of Waitress Headache
Lancet 378:1824, Libera, D.D.,et al, 2011

Syndrome of Inappropriate Antidiuresis May Herald or Accompany Neuromyelitis Optica
Neurol 77:1644-1645, Iorio, R.,et al, 2011

Hypereosinophilia in Patients with Multiple Sclerosis Treated with Natalizumab
Neurol 77:1561-1564, Abbas, M.,et al, 2011

Longitudinal Change of Biomakers in Cognitive Decline
Arch Neurol 68:1257-1266,1237, Lo, R.Y.,et al, 2011

Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Ann Neurol 69:292-302, 234, Polman,C.H.,et al, 2011

Asymptomatic Spinal Cord Lesions Predict Disease Progression in Radiologically Isolated Syndrome
Neurol 76:686-692, 680, Okuda,D.T.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Phase III Dose-Comparison Study of Glatiramer Acetate for Multiple Sclerosis
Ann Neurol 69:75-82, Comi,G.,et al, 2011

When A Brain Lesion Necessitates Chest CT
Conn Med 75:143-146, Finelli,P.F., 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011

CSF Complements Serum for Evaluating Paraneoplastic Antibodies and NMO-IgG
Neurol 76:1108-1110, McKeon,A.,et al, 2011

Clinical and Functional Outcome and Factors Predicting Prognosis in Osmotic Demyelination Syndrome (Central Pontine and/or Extrapontine Myelinolysis) in 25 Patients
JNNP 82:326-331, Kallakatta,R.N.,et al, 2011

Prior Suggestive Symptoms in One-Third of Patients Consulting for a "First" Demyelinating Event
JNNP 82:323-325, Gout,O.,et al, 2011

MRI Only Conversion to Multiple Sclerosis Following a Clinically Isolated Syndrome
JNNP 82:176-179, Chard,D.T.,et al, 2011

Demographic and Clinical Characteristics of Malignant Multiple Sclerosis
Neurol 76:1996-2001, Gholipour, T.,et al, 2011

Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimers Disease
AJNR 31:347-354, Walhovd, K.B.,et al, 2010

Safety and Efficacy of Natalizumab in Children With Multiple Sclerosis
Neurol 75:912-917, Ghezzi,A.,et al, 2010



Showing articles 300 to 350 of 4627 << Previous Next >>